UBC PiMS Research Group

Pharmacoepidemiology in Multiple Sclerosis Research Group

Genetic marker for drug risk in multiple sclerosis offers path toward precision medicine

via: Centreforbrainhealth.ca A team of researchers has uncovered a specific gene variant associated with an adverse drug reaction resulting in liver injury in a people with multiple sclerosis (MS). It is the first time researchers have been able to establish a validated genetic marker for a drug-induced harm in people with MS. Published today in […]

A constellation of symptoms presages first definitive signs of multiple sclerosis

Jose MA Wijandnd's study 'Five years before multiple sclerosis onset: Phenotyping the prodrome' is now published in MSJ.

New Article: Sun exposure over the life course and associations with multiple sclerosis

Neurology has recently published Helen Tremlett's article Sun exposure over the life course and associations with multiple sclerosis.

PiMS research featured in the Chronicle of Neurology & Psychiatry

Helen Tremlett’s ECTRIMS-ACTRIMS presentation was featured in the December 2017 issue of The Chronicle of Neurology & Psychiatry. Please find the coverage on pages 10 and 11 here.  
❙ ❙ « 1 / 4 »

Welcome to the UBC PiMS Group Website

Our research group is physically located within the Djavid Mowafaghian Centre for Brain Health and University of British Columbia’s hospital. We are part of the Department of Medicine and Division of Neurology. If that wasn’t enough, we are also affiliated with the Vancouver Coastal Health Research Institute.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia